These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


312 related items for PubMed ID: 15875726

  • 21. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
    Takahashi H, Wada K, Takizawa S, Sakurai G, Hanano M, Niwano H, Tatewaki W, Shibata A.
    Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
    [Abstract] [Full Text] [Related]

  • 22. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
    Song KS, Kim YA, Kim HK, Park Q.
    Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
    [Abstract] [Full Text] [Related]

  • 23. Diagnosis of disseminated intravascular coagulation. Role of D-dimer.
    Carr JM, McKinney M, McDonagh J.
    Am J Clin Pathol; 1989 Mar; 91(3):280-7. PubMed ID: 2646905
    [Abstract] [Full Text] [Related]

  • 24. Performance of the automated and rapid STA Liatest D-dimer on the STA-R analyzer.
    Waser G, Kathriner S, Wuillemin WA.
    Thromb Res; 2005 Mar; 116(2):165-70. PubMed ID: 15907532
    [Abstract] [Full Text] [Related]

  • 25. Analytical comparison of AxSYM, HemosIL DD HS and Innovance D-dimer immunoassays with the Vidas D-dimer.
    Salvagno GL, Lippi G, Manzato F, Giavarina D, Montagnana M, Poli G, Guidi GC.
    Int J Lab Hematol; 2009 Aug; 31(4):475-7. PubMed ID: 18503567
    [No Abstract] [Full Text] [Related]

  • 26. [Evaluation of novel assays for the detection of crosslinked fibrin degradation products in whole blood by the agglutination of the red blood cells].
    Kuroso K, Isogai N, Koike K, Fukutake K, Fujimaki M.
    Rinsho Byori; 1992 Dec; 40(12):1281-6. PubMed ID: 1307633
    [Abstract] [Full Text] [Related]

  • 27. Performance evaluation of a new rapid quantitative assay system for measurement of D-dimer in plasma and whole blood: PATHFAST D-dimer.
    Dempfle CE, Suvajac N, Elmas E, Borggrefe M.
    Thromb Res; 2007 Dec; 120(4):591-6. PubMed ID: 17175010
    [Abstract] [Full Text] [Related]

  • 28. [Hemostatic changes before and after the onset of disseminated intravascular coagulation].
    Wada H, Tanigawa M, Takagi M, Suzuki H, Mori Y, Ohta T, Kobayashi T, Kita K, Tanaka I, Yamaguchi T.
    Rinsho Ketsueki; 1989 Oct; 30(10):1755-62. PubMed ID: 2593241
    [Abstract] [Full Text] [Related]

  • 29. A retrospective study of canine D-dimer concentrations measured using an immunometric "Point-of-Care" test.
    Dewhurst E, Cue S, Crawford E, Papasouliotis K.
    J Small Anim Pract; 2008 Jul; 49(7):344-8. PubMed ID: 18638058
    [Abstract] [Full Text] [Related]

  • 30. Prototype quantitative assay for fibrinogen/fibrin degradation products. Clinical evaluation.
    Sigal SH, Cembrowski GS, Shattil SJ, Brown NM, Schifreen RS, Schwartz MW.
    Arch Intern Med; 1987 Oct; 147(10):1790-3. PubMed ID: 3662708
    [Abstract] [Full Text] [Related]

  • 31. [Assay of products of fibrin and fibrinogen degradation in disseminated intravascular coagulations. Evaluation of a new technique].
    Borschneck C, Dreyfus M, Bridey F, Edouard D, Meyer D.
    Presse Med; 1987 Oct; 24(17):799-802. PubMed ID: 7630868
    [Abstract] [Full Text] [Related]

  • 32. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE.
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [Abstract] [Full Text] [Related]

  • 33. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles.
    Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN.
    Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
    Marder VJ, Cruz GO, Schumer BR.
    Thromb Haemost; 1977 Apr 30; 37(2):183-91. PubMed ID: 577622
    [Abstract] [Full Text] [Related]

  • 35. [Quantitative analysis of crosslinked fibrin degradation products (XDP) in several diseases].
    Saito M, Asakura H, Ito K, Joukaji H, Uotani C, Kumabashiri I, Matsuda T.
    Rinsho Ketsueki; 1988 Nov 30; 29(11):2042-7. PubMed ID: 3236412
    [No Abstract] [Full Text] [Related]

  • 36. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN.
    Thromb Haemost; 1983 Aug 30; 50(2):591-4. PubMed ID: 6356456
    [Abstract] [Full Text] [Related]

  • 37. Usefulness of a latex agglutination assay for FDP D-dimer to demonstrate the presence of postmortem blood.
    Sakurada K, Sakai I, Sekiguchi K, Shiraishi T, Ikegaya H, Yoshida K.
    Int J Legal Med; 2005 May 30; 119(3):167-71. PubMed ID: 15654628
    [Abstract] [Full Text] [Related]

  • 38. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG, Momot AP, Cherkashin GV.
    Ter Arkh; 1984 May 30; 56(6):106-9. PubMed ID: 6474366
    [Abstract] [Full Text] [Related]

  • 39. [A new method for determination of DD/E complex using latex agglutination].
    Soe G, Kohno I, Motojima M, Saito M, Matsuda M, Terukina S.
    Rinsho Byori; 1989 Apr 30; Spec No 81():176-82. PubMed ID: 2754805
    [No Abstract] [Full Text] [Related]

  • 40. Evaluation of early detection and management of disseminated intravascular coagulation among Alexandria University pediatric intensive care patients.
    El-Nawawy A, Abbassy AA, El-Bordiny M, Essawi S.
    J Trop Pediatr; 2004 Dec 30; 50(6):339-47. PubMed ID: 15537719
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.